Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000633037 | SCV000754249 | uncertain significance | Spastic paraplegia | 2022-06-04 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 2714 of the SACS protein (p.Ser2714Leu). This variant is present in population databases (rs762610527, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SACS-related conditions. ClinVar contains an entry for this variant (Variation ID: 527993). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome Diagnostics Laboratory, |
RCV001849004 | SCV002105092 | uncertain significance | Hereditary spastic paraplegia | 2021-12-20 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835887 | SCV002086213 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2021-03-24 | no assertion criteria provided | clinical testing |